secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hoth Therapeutics, Inc. (HOTH)
CIK:        0001711786
Form:       8-K
Filed at:   2026-04-16T23:59:59+00:00
Accession:  0001213900-26-044741
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hoth Therapeutics resumes ATM equity offering under existing H.C. Wainwright agreement
--------------------------------------------------------------------------------

- On April 16, 2026, Hoth filed a new prospectus supplement to resume sales of common stock under its ATM agreement with H.C. Wainwright.
- The ATM offering was previously suspended on April 1, 2026, but the Sales Agreement remained in effect.
- The new prospectus supplement relates to the company's existing effective S-3 registration statement (File No. 333-291566).
- No specific terms (size, price, or expected proceeds) were disclosed in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711786/000121390026044741/0001213900-26-044741-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711786/000121390026044741/ea0286719-8k_hoth.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-044741

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer